It was found that STAT4 serum concentration was statistically significantly lower in MS patients compared with the control group (median (IQR): 0.16 (0.09) vs. 0.26 (0.42), p = 0.007) (Figure 2). The gene discussed is STAT4; the disease is myeloid sarcoma.